pharmaceuticals
pharmaceuticals Articles
CVS Health has faced strong headwinds since last year’s acquisition of health insurer Aetna, but its upcoming earnings report could prove to be a turning point.
Published:
AbbVie released better than expected fourth-quarter financial results before the markets opened on Friday.
Published:
Merck reported fourth-quarter financial results before the markets opened on Wednesday that were essentially in line with expectations, yet shares retreated in early trading.
Published:
Merck is scheduled to release its fourth-quarter financial results before the markets open on Wednesday. Analysts are looking for year-over-year growth on the top and bottom lines.
Published:
A positive research call indicates that Madrigal Pharmaceuticals shares could deliver more than 100% upside to investors over the coming year or so.
Published:
Pfizer stock retreated after it released a disappointing fourth-quarter earnings report before the opening bell Tuesday.
Published:
The January 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
If there is one group that can produce stock gains regardless of the daily market activities, that would be biotechnology and emerging pharmaceuticals. Coming up with a new approach or new way to...
Published:
These three health care companies included are expected to report their earnings on Tuesday morning.
Published:
As with almost all pandemic scares and other national and global issues, some speculative stocks manage to see their shares rise sharply.
Published:
Akcea Therapeutics and Ionis Pharmaceuticals each made handy gains on Wednesday after the firms reported midstage results for their cardiovascular disease study.
Published:
Neurotrope released a corporate update after analyzing data from its recently reported Phase 2 confirmatory clinical trial examining moderately severe to severe Alzheimer's disease patients.
Published:
When companies see their shares rise by 100% or more in a single day, it's usually because of a buyout or an extremely positive change in a company's future prospects. For Genprex, it was a nod from...
Published:
For health care investors, 2020 looks like a potentially good year after an especially fruitful JPMorgan Healthcare Conference this past week.
Published:
The December 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.